Connection

SRIDEVI DEVARAJ to Tumor Necrosis Factor-alpha

This is a "connection" page, showing publications SRIDEVI DEVARAJ has written about Tumor Necrosis Factor-alpha.
Connection Strength

0.944
  1. Circulating versus cellular biomarkers of inflammation in Type 1 diabetes: the superiority of C-reactive protein. Cytokine. 2012 Oct; 60(1):318-20.
    View in: PubMed
    Score: 0.275
  2. Alpha-tocopherol decreases tumor necrosis factor-alpha mRNA and protein from activated human monocytes by inhibition of 5-lipoxygenase. Free Radic Biol Med. 2005 May 01; 38(9):1212-20.
    View in: PubMed
    Score: 0.168
  3. Antisense to protein kinase C-alpha and p47phox attenuates the pro-inflammatory effects of human C-reactive protein in macrophages of biobreeding diabetic rats. Diab Vasc Dis Res. 2012 Oct; 9(4):315-9.
    View in: PubMed
    Score: 0.069
  4. Epigenetic regulation of high glucose-induced proinflammatory cytokine production in monocytes by curcumin. J Nutr Biochem. 2011 May; 22(5):450-8.
    View in: PubMed
    Score: 0.060
  5. Correlation of microvascular abnormalities and endothelial dysfunction in Type-1 Diabetes Mellitus (T1DM): a real-time intravital microscopy study. Clin Hemorheol Microcirc. 2009; 42(4):285-95.
    View in: PubMed
    Score: 0.054
  6. Gamma-tocopherol supplementation alone and in combination with alpha-tocopherol alters biomarkers of oxidative stress and inflammation in subjects with metabolic syndrome. Free Radic Biol Med. 2008 Mar 15; 44(6):1203-8.
    View in: PubMed
    Score: 0.050
  7. Increased toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: further evidence of a proinflammatory state. J Clin Endocrinol Metab. 2008 Feb; 93(2):578-83.
    View in: PubMed
    Score: 0.050
  8. Direct demonstration of an antiinflammatory effect of simvastatin in subjects with the metabolic syndrome. J Clin Endocrinol Metab. 2006 Nov; 91(11):4489-96.
    View in: PubMed
    Score: 0.046
  9. Development of an in vitro screening assay to test the antiinflammatory properties of dietary supplements and pharmacologic agents. Clin Chem. 2005 Dec; 51(12):2252-6.
    View in: PubMed
    Score: 0.043
  10. Defining the proinflammatory phenotype using high sensitive C-reactive protein levels as the biomarker. J Clin Endocrinol Metab. 2005 Aug; 90(8):4549-54.
    View in: PubMed
    Score: 0.042
  11. (-)-Epicatechin attenuates high-glucose-induced inflammation by epigenetic modulation in human monocytes. Eur J Nutr. 2017 Apr; 56(3):1369-1373.
    View in: PubMed
    Score: 0.022
  12. Advanced glycation endproducts induce fibrogenic activity in nonalcoholic steatohepatitis by modulating TNF-a-converting enzyme activity in mice. Hepatology. 2013 Oct; 58(4):1339-48.
    View in: PubMed
    Score: 0.019
  13. Pioglitazone inhibits Toll-like receptor expression and activity in human monocytes and db/db mice. Endocrinology. 2009 Aug; 150(8):3457-64.
    View in: PubMed
    Score: 0.014
  14. C-reactive protein decreases interleukin-10 secretion in activated human monocyte-derived macrophages via inhibition of cyclic AMP production. Arterioscler Thromb Vasc Biol. 2006 Nov; 26(11):2469-75.
    View in: PubMed
    Score: 0.011
  15. Is C-reactive protein an innocent bystander or proatherogenic culprit? C-reactive protein promotes atherothrombosis. Circulation. 2006 May 02; 113(17):2135-50; discussion 2150.
    View in: PubMed
    Score: 0.011
  16. Antioxidant supplementation prevents exercise-induced lipid peroxidation, but not inflammation, in ultramarathon runners. Free Radic Biol Med. 2004 May 15; 36(10):1329-41.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.